ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 063

Musculoskeletal Ultrasound Assessment in Pediatric Knee Hypermobility

Laura Ballenger1, Ann Salvator 2 and Edward Oberle 1, 1Division of Rheumatology, Nationwide Children's Hospital, Columbus, 2Biostatistics Resource at Nationwide Children's Hospital, Columbus

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: hypermobility, Pediatric rheumatology, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: While musculoskeletal ultrasound (MSUS) use in pediatric rheumatology is becoming more common, the majority of pediatric MSUS literature continues to focus on ultrasound findings in healthy children and juvenile idiopathic arthritis with little discussion of other musculoskeletal problems that may mimic arthritis such as joint hypermobility. Chronic joint pain related to hypermobility is a common referral to pediatric rheumatology clinics. Our aim is to describe the MSUS characteristics of the knee in a population with joint hypermobility and pain in comparison to hypermobile children without pain and children without hypermobility or pain.

Methods: Patients were recruited and assigned into three groups for a case-control study. Inclusion criteria for the case group were patient age ≥ 14 years, >10 degrees of knee hyperextension on goniometer measurement, and pain score ≥ 1 (out of 10) in the knee over the past month. Control patients were matched by age and gender. One control group had knee hypermobility without pain symptoms (pain score = 0). Another control group had no knee hypermobility (≤10 degrees of knee hyperextension) and no pain symptoms. Patients could not have a current diagnosis associated with arthritis, history of previous knee surgery, or history of knee trauma within the month prior to evaluation. Demographic and clinical information including Beighton score were collected. A rheumatology fellow obtained B-mode and Doppler MSUS of each knee. A blinded rheumatologist scored the images according to a recently published protocol for synovial effusion, synovial hypertrophy, hyperemia, and tendon abnormalities. Descriptive statistics are used for demographic variables, medication use, laboratory parameters and MSUS findings. Poisson regression with robust standard errors is used to evaluate risk of synovial effusion and synovial effusion/hypertrophy quantitative score.

Results: To date, 80 knees were evaluated with ultrasound. MSUS abnormalities are seen in 65 of 80 (81%) of all ultrasounds with abnormalities in 31 of 32 (97%) knees in the case group, 15 of 22 (68%) knees in the hypermobility/no pain group, and 19 of 26 (73%) knees in the no hypermobility/no pain group. The most frequent finding was synovial effusion in 21 of 32 (66%) knees of the case group. The finding was also frequent in the control groups in 10 of 22 (45%) knees in the hypermobility/no pain group and 13 of 26 (50%) knees in the no hypermobility/no pain group. Only two of 80 total knees (2%) had positive Doppler signal in the synovium. There were no significant differences between the groups for the risk of effusion or increased synovial effusion/hypertrophy quantitative score.

Conclusion: A high frequency of abnormalities is seen in all knee ultrasounds obtained in this study. Many knees in all groups had synovial effusion which suggests this finding may be physiologic rather than an association with joint hypermobility or pain symptoms. Few knees had positive Doppler signal which may be helpful to differentiate patients with abnormalities related to hypermobility or physiologic changes versus inflammatory arthritis. Further study is needed to assess if any abnormal findings are associated with reported pain symptoms.


Disclosure: L. Ballenger, None; A. Salvator, None; E. Oberle, None.

To cite this abstract in AMA style:

Ballenger L, Salvator A, Oberle E. Musculoskeletal Ultrasound Assessment in Pediatric Knee Hypermobility [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/musculoskeletal-ultrasound-assessment-in-pediatric-knee-hypermobility/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-ultrasound-assessment-in-pediatric-knee-hypermobility/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology